Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients.

Lal, Suman

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients. [electronic resource] - Pharmacogenomics Jun 2007 - 567-75 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1744-8042

10.2217/14622416.8.6.567 doi


Adult
Aged
Asian People--genetics
Breast Neoplasms--drug therapy
Doxorubicin--analogs & derivatives
Female
Gene Frequency--drug effects
Genetic Variation
Humans
Middle Aged
Organic Cation Transport Proteins--genetics
Polymorphism, Genetic--drug effects